Septama Abdi Wira, Xiao Jianbo, Panichayupakaranant Pharkphoom
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla, Thailand.
Faculty of Pharmacy, University of Sumatera Utara, Jalan Tri Dharma No. 5, 20155 Medan, Sumatera Utara, Indonesia.
J Intercult Ethnopharmacol. 2017 Apr 3;6(2):186-191. doi: 10.5455/jice.20170327073745. eCollection 2017 Apr-Jun.
AIM/BACKGROUNDS: Artocarpanone isolated from L. (Moraceae) exhibits antibacterial activity. The present study investigated synergistic activity between artocarpanone and tetracycline, ampicillin, and norfloxacin, respectively, against methicillin-resistant (MRSA), , and .
A broth microdilution method was used for evaluating antibacterial susceptibility. Synergistic effects were identified using a checkerboard method, and a bacterial cell membrane disruption was investigated by assay of released 260 nm absorbing materials following bacteriolysis.
Artocarpanone exhibited weak antibacterial activity against MRSA and with minimum inhibitory concentrations values of 125 and 500 μg/mL, respectively. However, the compound showed strong antibacterial activity against (7.8 μg/mL). The interaction between artocarpanone and all tested antibiotics revealed indifference and additive effects against and (fractional inhibitory concentration index [FICI] values of 0.75-1.25). The combination of artocarpanone (31.2 μg/mL) and norfloxacin (3.9 μg/mL) resulted in synergistic antibacterial activity against MRSA, with an FICI of 0.28, while the interaction between artocarpanone and tetracycline, and ampicillin showed an additive effect, with an FICI value of 0.5. A time-kill assay also indicated that artocarpanone had a synergistic effect on the antibacterial activity of norfloxacin. In addition, the combination of artocarpanone and norfloxacin altered the membrane permeability of MRSA.
These findings suggest that artocarpanone may be used to enhance the antibacterial activity of norfloxacin against MRSA.
目的/背景:从桑科波罗蜜属植物中分离得到的波罗蜜酮具有抗菌活性。本研究分别考察了波罗蜜酮与四环素、氨苄西林和诺氟沙星对耐甲氧西林金黄色葡萄球菌(MRSA)、[此处原文缺失两种细菌名称]和[此处原文缺失一种细菌名称]的协同活性。
采用肉汤微量稀释法评估抗菌药敏性。使用棋盘法确定协同作用,并通过检测细菌裂解后释放的260nm吸光物质来研究细菌细胞膜的破坏情况。
波罗蜜酮对MRSA和[此处原文缺失一种细菌名称]表现出较弱的抗菌活性,最低抑菌浓度值分别为125和500μg/mL。然而,该化合物对[此处原文缺失一种细菌名称]表现出较强的抗菌活性(7.8μg/mL)。波罗蜜酮与所有测试抗生素之间的相互作用对[此处原文缺失两种细菌名称]显示为无关和相加作用(部分抑菌浓度指数[FICI]值为0.75 - 1.25)。波罗蜜酮(31.2μg/mL)与诺氟沙星(3.9μg/mL)联合使用对MRSA产生协同抗菌活性,FICI为0.28,而波罗蜜酮与四环素和氨苄西林之间的相互作用显示为相加作用,FICI值为0.5。时间杀菌试验也表明波罗蜜酮对诺氟沙星的抗菌活性有协同作用。此外,波罗蜜酮与诺氟沙星联合使用改变了MRSA的膜通透性。
这些发现表明波罗蜜酮可用于增强诺氟沙星对MRSA的抗菌活性。